The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention Deficit Hyperactivity Disorder (ADHD) is a psychological condition thought to affect approximately 3-7% of school-aged children in the United States.

A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Attention deficit–hyperactivity disorder (ADHD) is characterized by the inability to marshal and sustain attention, modulate activity level, and moderate impulsive actions.

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

Many with ADHD grieve a life they feel they’ve missed. Healing begins by naming it—and choosing a new way forward.

ATTENTION deficit hyperactivity disorder (ADHD) is a common condition that affects people's behaviour. Up to five per cent of school-aged children and four per cent of adults may be battling with ...

Tannock, R. in Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: an Evidence-Based Approach (eds Jensen, P. & Cooper, J.) (American Medical Association Press, New York, in the ...